AI assistant
ARDELYX, INC. — Director's Dealing 2015
Feb 7, 2015
32003_dirs_2015-02-06_4d11d67a-b051-4bc7-b097-e4ae0c83d267.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ARDELYX, INC. (ARDX)
CIK: 0001437402
Period of Report: 2015-02-04
Reporting Person: Jacobs Jeffrey W (VP, Chemistry)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-04 | Common Stock | M | 6416 | $1.08 | Acquired | 53082 | Direct |
| 2015-02-04 | Common Stock | M | 2472 | $1.08 | Acquired | 55554 | Direct |
| 2015-02-04 | Common Stock | S | 6388 | $16.0746 | Disposed | 49166 | Direct |
| 2015-02-04 | Common Stock | S | 2500 | $16.8204 | Disposed | 46666 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-04 | Stock Option (Right to Buy) | $1.08 | M | 6416 | Disposed | 2021-02-17 | Common Stock (6416) | Direct |
| 2015-02-04 | Stock Option (Right to Buy) | $1.08 | M | 2472 | Disposed | 2020-10-26 | Common Stock (2472) | Direct |
Footnotes
F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 24, 2014.
F2: This transaction was executed in multiple trades in prices ranging from $15.64 to $16.64, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3: This transaction was executed in multiple trades in prices ranging from $16.74 to $17.055, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4: The option is fully vested and exercisable.